Corrigendum to “The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population” [Journal of Affective Disorders 185 (2015) 149–155](S0165032715004061)(10.1016/j.jad.2015.06.040);The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population

Journal of Affective Disorders

Volumn 185, Issue , 2015, Pages 149-155

  Chen, Jianhua ^a,b,d   Wang, Meng ^a   Waheed Khan, Raja Amjad ^a   He, Kuanjun ^c   Wang, Qingzhong ^b   Li, Zhiqiang ^a   Shen, Jiawei ^a   Song, Zhijian ^a   Li, Wenjin ^a   Wen, Zujia ^a   Jiang, Yiwen ^a   Xu, Yifeng ^b   Shi, Yongyong ^a,d   Ji, Weidong ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^d Changning Mental Health Center   (China)

Author keywords

Association Study; GSK3B gene; Major depressive disorder; Overlapping genetic risk factors; Schizophrenia; SNP

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84953712624     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.06.018     Document Type: Erratum

References (56)

1. P. Andrade Filho, A. Letra, A. Cramer, J. Prasad, G. Garlet, A. Vieira, R. Ferris, R. Menezes Insights from studies with oral cleft genes suggest associations between WNT-pathway genes and risk of oral cancer J. Dent. Res. 90 2011 740 746
2. J.-M. Beaulieu, T.D. Sotnikova, W.-D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. USA 101 2004 5099 5104
3. F. Benedetti, S. Poletti, D. Radaelli, A. Bernasconi, R. Cavallaro, A. Falini, C. Lorenzi, A. Pirovano, S. Dallaspezia, C. Locatelli, G. Scotti, E. Smeraldi Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity Genes, Brain Behav. 9 2010 365 371
4. G. Blasi, F. Napolitano, G. Ursini, A. Di Giorgio, G. Caforio, P. Taurisano, L. Fazio, B. Gelao, M.T. Attrotto, L. Colagiorgio, G. Todarello, F. Piva, A. Papazacharias, R. Masellis, M. Mancini, A. Porcelli, R. Romano, A. Rampino, T. Quarto, M. Giulietti, B.K. Lipska, J.E. Kleinman, T. Popolizio, D.R. Weinberger, A. Usiello, A. Bertolino Association of GSK-3beta genetic variation with GSK-3beta expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia Am. J. Psychiatry 170 2013 868 876
5. M. Burmeister, M.G. McInnis, S. Zöllner Psychiatric genetics: progress amid controversy Nat. Rev. Genet. 9 2008 527 540
6. C.-D.GotP.G. Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis Lancet 381 2013 1371
7. M.P. Cunha, J. Budni, F.K. Ludka, F.L. Pazini, J.M. Rosa, A. Oliveira, M.W. Lopes, C.I. Tasca, R.B. Leal, A.L. Rodrigues Involvement of PI3K/Akt signaling pathway and its downstream intracellular targets in the antidepressant-like effect of creatine Mol. Neurobiol. 2015 (E-pub ahead of print)
8. E.S. Emamian, D. Hall, M.J. Birnbaum, M. Karayiorgou, J.A. Gogos Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia Nat. Genet. 36 2004 131 137
9. D. Falush, M. Stephens, J.K. Pritchard Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies Genetics 164 2003 1567 1587
10. D. Falush, M. Stephens, J.K. Pritchard Inference of population structure using multilocus genotype data: dominant markers and null alleles Mol. Ecol. Notes 7 2007 574 578
11. D. Galimberti, J. Macmurray, D. Scalabrini, C. Fenoglio, M. De Riz, C. Comi, D. Comings, F. Cortini, C. Villa, M. Serpente, C. Cantoni, E. Ridolfi, M.H. Fardipoor, M. Leone, F. Monaco, N. Bresolin, E. Scarpini GSK3beta genetic variability in patients with multiple sclerosis Neurosc. Lett. 497 2011 46 48
12. R.A. Gibbs, J.W. Belmont, P. Hardenbol, T.D. Willis, F. Yu, H. Yang, L.-Y. Ch'ang, W. Huang, B. Liu, Y. Shen The international HapMap project Nature 426 2003 789 796
13. M.O. Goodarzi, H.J. Antoine, M. Pall, J. Cui, X. Guo, R. Azziz Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome Fert. Steril. 87 2007 1473 1476
14. T.D. Gould, E.R. Dow, K.C. O'Donnell, G. Chen, H.K. Manji Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway CNS Neurol. Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurol. Disord.) 6 2007 193 204
15. H.D. Hosgood, I. Menashe, M. Shen, M. Yeager, J. Yuenger, P. Rajaraman, X. He, N. Chatterjee, N.E. Caporaso, Y. Zhu Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway Carcinogenesis 29 2008 1938 1943
16. M.J. Hubisz, D. Falush, M. Stephens, J.K. Pritchard Inferring weak population structure with the assistance of sample group information Mol. Ecol. Resour. 9 2009 1322 1332
17. M. Ikeda, N. Iwata, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, N. Ozaki No association of GSK3β gene (GSK3B) with Japanese schizophrenia Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 134 2005 90 92
18. B. Inkster, T.E. Nichols, P.G. Saemann, D.P. Auer, F. Holsboer, P. Muglia, P.M. Matthews Association of GSK3β polymorphisms with brain structural changes in major depressive disorder Arch. Gen. Psychiatry 66 2009 721 728
19. B. Inkster, T.E. Nichols, P.G. Saemann, D.P. Auer, F. Holsboer, P. Muglia, P.M. Matthews Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression Neuroimage 53 2010 908 917
20. D.H. Kavanagh, D.A. Savage, C.C. Patterson, A.J. McKnight, J.K. Crean, A.P. Maxwell, G.J. McKay Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy BMC Nephrol. 14 2013 126
21. B.H. King, C. Lord Is schizophrenia on the autism spectrum? Brain Res. 1380 2011 34 41
22. P.S. Klein, D.A. Melton A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. 93 1996 8455 8459
23. N. Kozlovsky, R. Belmaker, G. Agam Low GSK-3 activity in frontal cortex of schizophrenic patients Schizophr. Res. 52 2001 101 105
24. N. Kozlovsky, R. Belmaker, G. Agam GSK-3 and the neurodevelopmental hypothesis of schizophrenia Eur. Neuropsychopharmacol. 12 2002 13 25
25. N. Kozlovsky, C. Nadri, G. Agam Low GSK-3β in schizophrenia as a consequence of neurodevelopmental insult Eur. Neuropsychopharmacol. 15 2005 1 11
26. N. Kozlovsky, C. Shanon-Weickert, E. Tomaskovic-Crook, J. Kleinman, R. Belmaker, G. Agam Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients J. Neural Transm. 111 2004 1583 1592
27. K.Y. Lee, Y.M. Ahn, E.-J. Joo, S.-H. Jeong, J.S. Chang, S.-C. Kim, Y.S. Kim No association of two common SNPs at position- 1727A/T,- 50C/T of< i> GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population Neurosci. Lett. 395 2006 175 178
28. D.F. Levinson, J. Duan, S. Oh, K. Wang, A.R. Sanders, J. Shi, N. Zhang, B.J. Mowry, A. Olincy, F. Amin Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications Am. J. Psychiatry 168 2011 302 316
29. D.A. Lewis, P. Levitt Schizophrenia as a disorder of neurodevelopment Annu. Rev. Neurosci. 25 2002 409 432
30. M. Li, Y. Mo, X.-j Luo, X. Xiao, L. Shi, Y.-m Peng, X.-b Qi, X.-y Liu, L.-d Yin, H.-b Diao Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility Schizophren. Res. 133 2011 165 171
31. X. Li, A.B. Friedman, W. Zhu, L. Wang, S. Boswell, R.S. May, L.L. Davis, R.S. Jope Lithium regulates glycogen synthase kinase-3β in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder Biol. Psychiatry 61 2007 216 222
32. X. Li, W. Zhu, M.-S. Roh, A.B. Friedman, K. Rosborough, R.S. Jope In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 29 2004 1426
33. S. Liu, N. Sun, Y. Xu, C. Yang, Y. Ren, Z. Liu, X. Cao, Y. Sun, Q. Xu, K. Zhang Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform Genetic Test. Mol. Biomark. 16 2012 1382 1389
34. Z. Liu, H. Guo, X. Cao, C. Cheng, C. Yang, C. Xu, A. Zhang, N. Sun, X. Li, K. Zhang A combined study of GSK3beta polymorphisms and brain network topological metrics in major depressive disorder Psychiatry Res. 223 2014 210 217
35. C.Y. Logan, R. Nusse The Wnt signaling pathway in development and disease Annu. Rev. Cell Dev. Biol. 20 2004 781 810
36. X. Luo, M. Li, L. Huang, S. Steinberg, M. Mattheisen, G. Liang, G. Donohoe, Y. Shi, C. Chen, W. Yue Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene Mol. Psychiatry 2013
37. J. Meng, Y. Shi, X. Zhao, J. Zhou, Y. Zheng, R. Tang, G. Ma, X. Zhu, Z. He, Z. Wang No significant association between the genetic polymorphisms in the GSK-3β gene and schizophrenia in the Chinese population J. Psychiatr. Res. 42 2008 365 370
38. R.T. Moon, J.D. Brown, M. Torres WNTs modulate cell fate and behavior during vertebrate development Trends Genet. 13 1997 157 162
39. M.C. O'Donovan, N.J. Craddock, M.J. Owen Genetics of psychosis; insights from views across the genome Hum. Genet. 126 2009 3 12
40. J. Papkoff, M. Aikawa WNT-1 and HGF regulate GSK3β activity and β-catenin signaling in mammary epithelial cells Biochem. Biophys. Res. Commun. 247 1998 851 858
41. Psychiatric Genetic Consortium, 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510), 421-427.
42. J. Platenik, Z. Fisar, R. Buchal, R. Jirak, E. Kitzlerova, M. Zverova, J. Raboch GSK3beta, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression Progr. Neuro-psychopharmacol. Biol. Psychiatry 50 2014 83 93
43. S.M. Purcell, N.R. Wray, J.L. Stone, P.M. Visscher, M.C. O'Donovan, P.F. Sullivan, P. Sklar, D.M. Ruderfer, A. McQuillin, D.W. Morris Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752
44. J. Rapoport, A. Chavez, D. Greenstein, A. Addington, N. Gogtay Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited J. Am. Acad. Child Adolesc. Psychiatry 48 2009 10 18
45. S. Ripke, C. O'Dushlaine, K. Chambert, J.L. Moran, A.K. Kähler, S. Akterin, S.E. Bergen, A.L. Collins, J.J. Crowley, M. Fromer Genome-wide association analysis identifies 13 new risk loci for schizophrenia Nat. Genet. 45 2013 1150 1159
46. S. Ripke, A.R. Sanders, K.S. Kendler, D.F. Levinson, P. Sklar, P.A. Holmans, D.-Y. Lin, J. Duan, R.A. Ophoff, O.A. Andreassen Genome-wide association study identifies five new schizophrenia loci Nat. Genet. 43 2011 969
47. S. Ripke, N.R. Wray, C.M. Lewis, S.P. Hamilton, M.M. Weissman, G. Breen, E.M. Byrne, D.H. Blackwood, D.I. Boomsma, S. Cichon A mega-analysis of genome-wide association studies for major depressive disorder Mol. Psychiatry 18 2012 497 511
48. C. Scassellati, C. Bonvicini, J. Perez, L. Bocchio-Chiavetto, G.B. Tura, G. Rossi, G. Racagni, M. Gennarelli Association study of -1727A/T, -50C/T and (CAA) n repeat GSK-3β gene polymorphisms with schizophrenia Neuropsychobiology 50 2004 16 20
49. C. Scassellati, C. Bonvicini, J. Perez, L. Bocchio-Chiavetto, G.B. Tura, G. Rossi, G. Racagni, M. Gennarelli Association study of -1727A/T, -50C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia Neuropsychobiology 50 2004 16 20
50. P. Sklar, S. Ripke, L.J. Scott, O.A. Andreassen, S. Cichon, N. Craddock, H.J. Edenberg, J.I. Nurnberger, M. Rietschel, D. Blackwood Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 Nat. Genet. 43 2011 977
51. R.P. Souza, M.A. Romano-Silva, J.A. Lieberman, H.Y. Meltzer, A.H. Wong, J.L. Kennedy Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response Psychopharmacology 200 2008 177 186
52. H. Tang, N. Shen, H. Jin, D. Liu, X. Miao, L.Q. Zhu GSK-3beta polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis Mol. Neurobiol. 48 2013 404 411
53. E.M. Wexler, D.H. Geschwind DISC1: a schizophrenia gene with multiple personalities Neuron 72 2011 501 503
54. C. Yang, Y. Xu, N. Sun, Y. Ren, Z. Liu, X. Cao, K. Zhang The combined effects of the< i> BDNF and< i> GSK3B genes modulate the relationship between negative life events and major depressive disorder Brain Res. 1355 2010 1 6
55. Y. Yong, H. Lin SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci Cell Res. 15 2005 97 98
56. K. Zhang, C. Yang, Y. Xu, N. Sun, H. Yang, J. Liu, Q. Xu, Y. Shen Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population J. Neural Transm. 117 2010 393 401